Source: European Parliament
Medicines and medical devices are subject to the rules of the single market and have a direct impact on people’s health. A robust legal framework is in place to protect public health and guarantee the safety of these products. An adequate and affordable supply of medicines, the fight against antimicrobial resistance, the ethical conduct of clinical trials, the use of artificial intelligence in medical devices and incentives for research and development are just some of the key issues the EU deals with in this field.